Toggle navigation
Oxford Finance
Team
Life Sciences
Healthcare
Real Estate
Leveraged Lending
News
Contact Us
Recent News
Investor Relations
Leveraged Lending
Life Sciences
Real Estate
May 5, 2022
Pliant Therapeutics Enters into $100 million Loan Facility Agreement with Oxford Finance to Support Ongoing Development of PLN-74809
News | Life Sciences
April 25, 2022
Oxford Finance Healthcare Real Estate Q1 2022 Recap
News | Healthcare | Real Estate
April 5, 2022
Oxford Finance Announces the Closing of a $75 Million Credit Facility With Fusion Pharmaceuticals
News | Life Sciences
March 28, 2022
Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors
News | Life Sciences
March 24, 2022
Oxford Finance Leads $660 Million Upsize Financing for Specialty Dental Brands
News | Healthcare | Leveraged Lending
March 17, 2022
Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of Sotagliflozin
News | Life Sciences
February 23, 2022
Rohit Gandhi Joins Oxford Finance’s Senior Lending Platform
News | Healthcare
February 15, 2022
Oxford Finance Announces the Closing of a $50 Million Credit Facility With OncoResponse
News | Life Sciences
February 14, 2022
Oxford Finance’s Healthcare Real Estate Group Closes Over $540 Million of Capital Commitments in 2021
News | Healthcare | Real Estate
February 7, 2022
Oxford Finance Closes $400 Million Senior Note Offering
News | Investor Relations
February 1, 2022
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
News | Life Sciences
January 27, 2022
Sierra Oncology Provides Financial Update to Support the Future Commercialization of Momelotinib
News | Life Sciences
1
2
3
4
…
11
Meet the team that speaks your language.
Contact Us
Meet the Team